Home  ›  Once You Have the Whooping Cough Vacine How Long Before You Can Be Around the Baby

Once You Have the Whooping Cough Vacine How Long Before You Can Be Around the Baby

Written By mercredi 9 mars 2022 Add Comment Edit

Homo disease acquired by the bacteria Bordetella pertussis

Medical condition

Whooping cough
Other names Pertussis, 100-twenty-four hour period coughing
Pertussis.jpg
A immature boy cough due to pertussis.
Specialty Infectious disease
Symptoms Runny nose, fever, coughing[ane]
Complications Vomiting, broken ribs, exhaustion[1] [ii]
Duration ~ ten weeks[3]
Causes Bordetella pertussis (spread through the air)[4]
Diagnostic method Nasopharyngeal swab[five]
Prevention Pertussis vaccine[half-dozen]
Treatment Antibiotics (if started early)[7]
Frequency 16.3 meg (2015)[8]
Deaths 58,700 (2015)[nine]

Whooping cough, as well known as pertussis or the 100-mean solar day coughing, is a highly contagious bacterial affliction.[i] [ten] Initial symptoms are usually similar to those of the cold with a runny nose, fever, and mild cough, but these are followed past weeks of severe coughing fits.[one] Following a fit of coughing, a loftier-pitched whoop sound or gasp may occur as the person breathes in.[1] The coughing may terminal for 10 or more weeks, hence the phrase "100-day cough".[iii] A person may cough so hard that they vomit, intermission ribs, or become very tired from the endeavor.[1] [2] Children less than one twelvemonth old may have niggling or no coughing and instead have periods where they practise not exhale.[1] The time between infection and the onset of symptoms is usually seven to ten days.[11] Disease may occur in those who have been vaccinated, only symptoms are typically milder.[1]

Pertussis is acquired by the bacterium Bordetella pertussis.[4] It is spread easily through the coughs and sneezes of an infected person.[4] [12] People are infectious from the start of symptoms until about three weeks into the coughing fits.[7] Those treated with antibiotics are no longer infectious after five days.[7] Diagnosis is by collecting a sample from the back of the olfactory organ and throat.[5] This sample can so be tested by either culture or past polymerase concatenation reaction.[5]

Prevention is mainly by vaccination with the pertussis vaccine.[6] Initial immunization is recommended between six and eight weeks of historic period, with four doses to be given in the first 2 years of life.[13] Protection from pertussis decreases over fourth dimension, so additional doses of vaccine are often recommended for older children and adults.[xiv] Antibiotics may be used to preclude the disease in those who have been exposed and are at risk of severe disease.[15] In those with the disease, antibiotics are useful if started within iii weeks of the initial symptoms, only otherwise have picayune effect in most people.[vii] In significant women and children less than one yr old, antibiotics are recommended within half dozen weeks of symptom onset.[seven] Antibiotics used include erythromycin, azithromycin, clarithromycin, or trimethoprim/sulfamethoxazole.[seven] Testify to back up interventions for the cough, other than antibiotics, is poor.[xvi] About l% of infected children less than a twelvemonth erstwhile require hospitalization and most 0.v% (1 in 200) dice.[1] [ii]

An estimated 16.3 1000000 people worldwide were infected in 2015.[8] Nigh cases occur in the developing world, and people of all ages may be affected.[6] [16] In 2015, pertussis resulted in 58,700 deaths – downwardly from 138,000 deaths in 1990.[9] [17] Outbreaks of the disease were offset described in the 16th century.[xi] The bacterium that causes the infection was discovered in 1906.[11] The pertussis vaccine became available in the 1940s.[11]

Signs and symptoms [edit]

The classic symptoms of pertussis are a paroxysmal cough, inspiratory whoop, and fainting, or vomiting subsequently coughing.[18] The cough from pertussis has been documented to cause subconjunctival hemorrhages, rib fractures, urinary incontinence, hernias, and vertebral avenue autopsy.[xviii] Violent coughing tin can cause the pleura to rupture, leading to a pneumothorax. Vomiting after a coughing spell or an inspiratory whooping audio on coughing, most doubles the likelihood that the affliction is pertussis. The absence of a paroxysmal cough or posttussive emesis, though, makes it almost half as likely.[18]

The disease usually starts with balmy respiratory symptoms include mild cough, sneezing, or a runny nose (known equally the catarrhal stage). Later one or 2 weeks, the coughing classically develops into uncontrollable fits, sometimes followed past a loftier-pitched "whoop" sound, as the person tries to inhale. Near l% of children and adults "whoop" at some point in diagnosed pertussis cases during the paroxysmal phase.

This stage usually lasts two to eight weeks, or sometimes longer. A gradual transition and so occurs to the convalescent stage, which usually lasts one to four weeks. This stage is marked by a decrease in paroxysms of coughing, although paroxysms may occur with subsequent respiratory infection for many months subsequently the onset of pertussis.[19]

Symptoms of pertussis can exist variable, especially between immunized and not-immunized people. Those that are immunized can present with a more mild infection; they may only have the paroxysmal cough for a couple of weeks, and it may lack the "whooping" characteristic.[20] Although immunized people have a milder form of the infection, they can spread the disease to others who are not immune.[twenty]

Incubation period [edit]

The time between exposure and the development of symptoms is on average vii–fourteen days (range 6–20 days),[21] rarely as long as 42 days.[22]

Cause [edit]

Pertussis is caused by the bacterium Bordetella pertussis. It is an airborne disease (through droplets) that spreads easily through the coughs and sneezes of an infected person.[iv]

Spread from other animals [edit]

Uncertainties have existed of B. pertussis and whooping cough equally a zoonotic affliction since effectually 1910[23] [24] but in the 1930s, cognition was gained that the bacteria lost their virulent power when repeatedly spread on agar media. This explained the difficulties to reproduce results from dissimilar studies every bit the pre-inoculating handlings of the bacteria were not standardized amidst scientists.[25]

Today it is established that at to the lowest degree some primate species are highly susceptible to B. pertussis and develop clinical whooping cough in high incidence when exposed to low inoculation doses.[26] [27] The bacteria may be nowadays in wild animal populations, but this is not confirmed by laboratory diagnosis, although whooping cough is known among wild gorillas.[28] Several zoos also take a long-standing custom of vaccinating their primates against whooping cough.[29]

Machinery [edit]

Later the leaner are inhaled, they initially adhere to the ciliated epithelium in the nasopharynx. Surface proteins of B. pertussis, including filamentous hemaglutinin and pertactin, mediate attachment to the epithelium. The leaner so multiply.[30] [31] In infants, who experience more than astringent disease, the bacteria spread down to the lungs.[31]

The leaner secretes a number of toxins. Tracheal cytotoxin, a fragment of peptidoglycan, kills ciliated epithelial cells and thereby inhibits the mucociliary elevator by which fungus and droppings are removed.[32] TCT may contribute to the cough characteristic of pertussis.[33] The cough may also be acquired by a yethoped-for identified "coughing toxin".[34] Pertussis toxin causes lymphocytosis by an unknown mechanism. The elevated number of white claret cells leads to pulmonary hypertension, a major cause of death by pertussis.[32] [31] In infants who develop encephalopathy, cerebral hemorrhage and cortical atrophy occur, likely due to hypoxia.[31]

Diagnosis [edit]

Gram stain of Bordetella pertussis

Based on symptoms [edit]

A md'due south overall impression is near effective in initially making the diagnosis.[35] Single factors are much less useful.[35] In adults with a coughing of less than 8 weeks, vomiting after coughing or a "whoop" is supportive.[36] If at that place are no bouts of coughing or in that location is a fever the diagnosis is unlikely.[36] In children who accept a cough of less than iv weeks vomiting afterward cough is somewhat supportive only not definitive.[36]

Lab tests [edit]

Methods used in laboratory diagnosis include culturing of nasopharyngeal swabs on a nutrient medium (Bordet–Gengou medium), polymerase concatenation reaction (PCR), direct fluorescent antibody (DFA), and serological methods (eastward.g. complement fixation test).[37] The bacteria can be recovered from the person merely during the kickoff three weeks of illness, rendering culturing and DFA useless later on this period, although PCR may have some limited usefulness for an boosted three weeks.

Serology may be used for adults and adolescents who accept already been infected for several weeks to determine whether antibody against pertussis toxin or some other virulence gene of B. pertussis is present at high levels in the blood of the person.[38]

Differential diagnosis [edit]

A like, milder illness is caused by B. parapertussis.[39]

Prevention [edit]

The principal method of prevention for pertussis is vaccination.[40] Evidence is insufficient to determine the effectiveness of antibiotics in those who have been exposed, only are without symptoms.[41] Preventive antibiotics, yet, are notwithstanding frequently used in those who have been exposed and are at high hazard of severe illness (such as infants).[6]

Vaccine [edit]

Pertussis vaccines are constructive at preventing illness[42] and are recommended for routine utilise by the World Health Arrangement[43] and the Us Centers for Affliction Control and Prevention.[44] The vaccine saved an estimated half a million lives in 2002.[43]

The multicomponent acellular pertussis vaccine is 71–85% effective, with greater effectiveness against more severe strains.[42] However, despite widespread vaccination, pertussis has persisted in vaccinated populations and is today "one of the most mutual vaccine-preventable diseases in Western countries".[45] The 21st-century resurgences in pertussis infections is attributed to a combination of waning immunity and bacterial mutations that elude vaccines.[45] [46]

Immunization does not confer lifelong immunity; a 2011 CDC written report indicated that protection may merely last three to six years. This covers childhood, which is the fourth dimension of greatest exposure and greatest adventure of death from pertussis.[xviii] [47]

An result of widespread immunization on society has been the shift of reported infections from children aged i–9 years to infants, adolescents, and adults, with adolescents and adults acting as reservoirs for B. pertussis and infecting infants who take had fewer than three doses of vaccine.[48]

Infection induces incomplete natural immunity that wanes over fourth dimension.[49] A 2005 study said estimates of the elapsing of infection-acquired amnesty range from seven to 20 years and the dissimilar results could exist the result of differences in levels of circulating B. pertussis, surveillance systems, and case definitions used. The written report said protective immunity after vaccination wanes afterwards 4–12 years.[50] One study suggested that the availability of vaccine exemptions increases the number of pertussis cases.[51]

Some studies have suggested that while acellular pertussis vaccines are constructive at preventing the illness, they take a express bear upon on infection and transmission, significant that vaccinated people could spread pertussis even though they may have only mild symptoms or none at all.[52] [53] Pertussis infection in these persons may be asymptomatic, or present as illness ranging from a mild coughing to classic pertussis with persistent cough (i.due east., lasting more than 7 days). Fifty-fifty though the disease may be milder in older persons, those who are infected may transmit the illness to other susceptible persons, including unimmunized or incompletely immunized infants. Older persons are ofttimes found to take the first instance in a household with multiple pertussis cases, and are ofttimes the source of infection for children.[xix]

Treatment [edit]

The antibiotics erythromycin, clarithromycin, or azithromycin are typically the recommended treatment.[41] Newer macrolides are often recommended due to lower rates of side furnishings.[six] Trimethoprim-sulfamethoxazole (TMP/SMX) may exist used in those with allergies to first-line agents or in infants who have a risk of pyloric stenosis from macrolides.[6]

A reasonable guideline is to treat people age >ane year within iii weeks of cough onset and infants age <1 yr and meaning women within 6 weeks of coughing onset. If the person is diagnosed tardily, antibiotics will not alter the form of the illness, and even without antibiotics, they should no longer be spreading pertussis.[6] When used early on, antibiotics decrease the duration of infectiousness, and thus prevent spread.[6] Short-term antibiotics (azithromycin for iii–5 days) are as effective equally long-term treatment (erythromycin x–14 days) in eliminating B. pertussis with fewer and less severe side furnishings.[41]

People with pertussis are virtually infectious during the first ii weeks following the onset of symptoms.[54]

Effective treatments of the cough associated with this status have not been developed.[55] The use of over the counter cough medications is discouraged and has not been found helpful.[twenty]

Prognosis [edit]

Inability-adapted life year for pertussis per 100,000 inhabitants as of 2004.

 No information

 Less than 50

 50–100

 100–150

 150–200

 200–250

 250–300

 300–350

 350–400

 400–450

 450–500

 500–550

 More than 550

While most good for you older children and adults fully recover, infection in newborns is specially astringent. Pertussis is fatal in an estimated 0.5% of US infants nether one year of age.[56] First-year infants are besides more than probable to develop complications, such equally: apneas (31%), pneumonia (12%), seizures (0.6%) and encephalopathy (0.fifteen%).[56] This may be due to the power of the bacterium to suppress the immune system.[57]

Epidemiology [edit]

Whooping cough deaths per one thousand thousand persons in 2012

 0–0.9

 1–i.9

 2–three

 4–four.9

 five–5.9

 half-dozen–32

 33–38

 39–44

 45–79

Worldwide, whooping cough affects effectually xvi one thousand thousand people yearly.[16] Ane estimate for 2013 stated it resulted in about 61,000 deaths – down from 138,000 deaths in 1990.[17] Another estimated 195,000 child deaths yearly from the disease worldwide.[58] This is despite more often than not high coverage with the DTP and DTaP vaccines. Pertussis is one of the leading causes of vaccine-preventable deaths worldwide.[59] Almost 90% of all cases occur in developing countries.[59]

Before vaccines, an average of 178,171 cases was reported in the U.S., with peaks reported every ii to five years; more than 93% of reported cases occurred in children nether 10 years of age. The actual incidence was likely much higher. Later vaccinations were introduced in the 1940s, pertussis incidence roughshod dramatically to approximately one,000 by 1976. Incidence rates have increased since 1980. In 2015, rates in the United States were 20,762 people.[threescore]

Pertussis is the simply vaccine-preventable disease that is associated with increasing deaths in the U.S. The number of deaths increased from four in 1996 to 17 in 2001, almost all of which were infants nether one year.[61] In Canada, the number of pertussis infections has varied between two,000 and 10,000 reported cases each twelvemonth over the last x years, and it is the about mutual vaccine-preventable affliction in Toronto.[62]

In 2009 Commonwealth of australia reported an average of x,000 cases a year, and the number of cases had increased.[63] In the U.S. pertussis in adults has increased significantly since near 2004.[64]

In 2017, India had a reported 23,766 reported pertussis cases, making it i of the highest reported number of cases of the year.[65] Other countries, such every bit Germany, had reported 16,183 cases, while Commonwealth of australia and People's republic of china had a reported number of 12,114 and 10,390 pertussis cases.[65]

United states outbreaks [edit]

An epidemiologist tests blood samples for pertussis during a 2010 outbreak.

In 2010, 10 babies in California died and health authorities declared an epidemic with 9 120 cases.[66] [67] They found that doctors had failed to correctly diagnose the babies' status during several visits.[68] Statistical assay identified significant overlap in communities with a cluster of nonmedical child exemptions and cases. The number of exemptions varied widely among communities, but tended to be highly clustered. In some schools, more than 75 % of parents filed for vaccination exemptions. The data propose vaccine refusal based on nonmedical reasons and personal belief exacerbated the outbreak. Other factors included reduced duration of amnesty post-obit the acellular vaccine and, the fact that about vaccinated adults and older children had not received a booster shot.[69] [70]

In Apr and May 2012, pertussis was declared to exist at epidemic levels in Washington, with 3,308 cases.[71] [72] [73] In December 2012 Vermont declared an epidemic of 522 cases.[74] Wisconsin had the highest incidence rate, with 3,877 cases, although it did not brand an official epidemic announcement.[73]

History [edit]

Discovery [edit]

B. pertussis was discovered in 1906 by Jules Bordet and Octave Gengou, who also developed the first serology and vaccine. Efforts to develop an inactivated whole-jail cell vaccine began soon after B. pertussis was cultured that year. In the 1920s, Louis West. Sauer developed a weak vaccine for whooping cough at Evanston Hospital (Evanston, IL). In 1925 Danish physician Thorvald Madsen was the first to test a whole-prison cell vaccine on a wide scale.[75] Madsen used the vaccine to control outbreaks in the Faroe Islands in the Northward Ocean.

Vaccine [edit]

In 1932 an outbreak of whooping cough hitting Atlanta, Georgia, prompting pediatrician Leila Denmark to begin her study of the illness. Over the next 6 years her piece of work was published in the Journal of the American Medical Association, and in partnership with Emory University and Eli Lilly & Company, she developed the first pertussis vaccine.[76] In 1942 American scientists Grace Eldering, Loney Gordon, and Pearl Kendrick combined the whole-cell pertussis vaccine with diphtheria and tetanus toxoids to generate the kickoff DTP combination vaccine.[77] To minimize the frequent side furnishings caused by the pertussis component, Japanese scientist Yuji Sato developed an acellular vaccine consisting of purified haemagglutinins (HAs: filamentous strep throat and leukocytosis-promoting-gene HA), which are secreted by B. pertussis. Sato's acellular pertussis vaccine was used in Japan starting in 1981.[78] After versions of the acellular vaccine in other countries consisted of additional defined components of B. pertussis and were frequently role of the DTaP combination vaccine.

References [edit]

  1. ^ a b c d east f yard h i "Pertussis (Whooping Cough) Signs & Symptoms". 22 May 2014. Archived from the original on 7 February 2015. Retrieved 12 February 2015.
  2. ^ a b c "Pertussis (Whooping Coughing) Complications". cdc.gov. 28 Baronial 2013. Archived from the original on 9 Feb 2015. Retrieved 12 February 2015.
  3. ^ a b "Pertussis (Whooping Cough) Fast Facts". cdc.gov. thirteen Feb 2014. Archived from the original on 7 February 2015. Retrieved 12 February 2015.
  4. ^ a b c d "Pertussis (Whooping Cough) Causes & Transmission". cdc.gov. iv September 2014. Archived from the original on 14 Feb 2015. Retrieved 12 February 2015.
  5. ^ a b c "Pertussis (Whooping Cough) Specimen Collection". cdc.gov. 28 August 2013. Archived from the original on 8 February 2015. Retrieved xiii Feb 2015.
  6. ^ a b c d e f g h Heininger U (February 2010). "Update on pertussis in children". Good Review of Anti-Infective Therapy. eight (2): 163–73. doi:10.1586/eri.09.124. PMID 20109046. S2CID 207217558.
  7. ^ a b c d e f "Pertussis (Whooping Cough) Treatment". cdc.gov. 28 August 2013. Archived from the original on 11 Feb 2015. Retrieved thirteen Feb 2015.
  8. ^ a b Vos, Theo; Allen, Christine; Arora, Megha; Barber, Ryan M.; Bhutta, Zulfiqar A.; Brownish, Alexandria; Carter, Austin; Casey, Daniel C.; Charlson, Fiona J.; Chen, Alan Z.; Coggeshall, Megan; Cornaby, Leslie; Dandona, Lalit; Dicker, Daniel J.; Dilegge, Tina; Erskine, Holly East.; Ferrari, Alize J.; Fitzmaurice, Christina; Fleming, Tom; Forouzanfar, Mohammad H.; Fullman, Nancy; Gething, Peter Westward.; Goldberg, Ellen M.; Graetz, Nicholas; Haagsma, Juanita A.; Hay, Simon I.; Johnson, Catherine O.; Kassebaum, Nicholas J.; Kawashima, Toana; et al. (Oct 2016). "Global, regional, and national incidence, prevalence, and years lived with inability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-half-dozen. PMC5055577. PMID 27733282.
  9. ^ a b Wang, Haidong; Naghavi, Mohsen; Allen, Christine; Barber, Ryan M.; Bhutta, Zulfiqar A.; Carter, Austin; Casey, Daniel C.; Charlson, Fiona J.; Chen, Alan Zian; Coates, Matthew M.; Coggeshall, Megan; Dandona, Lalit; Dicker, Daniel J.; Erskine, Holly East.; Ferrari, Alize J.; Fitzmaurice, Christina; Foreman, Kyle; Forouzanfar, Mohammad H.; Fraser, Maya S.; Fullman, Nancy; Gething, Peter W.; Goldberg, Ellen 1000.; Graetz, Nicholas; Haagsma, Juanita A.; Hay, Simon I.; Huynh, Chantal; Johnson, Catherine O.; Kassebaum, Nicholas J.; Kinfu, Yohannes; et al. (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific bloodshed for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Illness Written report 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC5388903. PMID 27733281.
  10. ^ Carbonetti NH (June 2007). "Immunomodulation in the pathogenesis of Bordetella pertussis infection and affliction". Current Opinion in Pharmacology. 7 (3): 272–8. doi:10.1016/j.coph.2006.12.004. PMID 17418639.
  11. ^ a b c d Atkinson W (May 2012). Pertussis Epidemiology and Prevention of Vaccine-Preventable Diseases (12th ed.). Public Wellness Foundation. pp. 215–230. ISBN9780983263135. Archived from the original on 29 July 2017.
  12. ^ "Pertussis". WHO. Archived from the original on 5 June 2015. Retrieved 23 March 2016.
  13. ^ "Revised guidance on the choice of pertussis vaccines: July 2014" (PDF). Relevé Épidémiologique Hebdomadaire. 89 (30): 337–xl. July 2014. PMID 25072068. Archived (PDF) from the original on thirteen February 2015.
  14. ^ "Pertussis vaccines: WHO position paper". Relevé Épidémiologique Hebdomadaire. 85 (40): 385–400. October 2010. PMID 20939150.
  15. ^ "Pertussis (Whooping Cough) Prevention". cdc.gov. ten October 2014. Archived from the original on eight February 2015. Retrieved 13 February 2015.
  16. ^ a b c Wang Thousand, Bettiol S, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, Harnden A (September 2014). "Symptomatic treatment of the cough in whooping cough". The Cochrane Database of Systematic Reviews. nine (ix): CD003257. doi:x.1002/14651858.CD003257.pub5. PMC7154224. PMID 25243777.
  17. ^ a b GBD 2013 Bloodshed Causes of Death Collaborators (January 2015). "Global, regional, and national age-sexual activity specific all-cause and crusade-specific bloodshed for 240 causes of decease, 1990–2013: a systematic analysis for the Global Burden of Disease Report 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC4340604. PMID 25530442.
  18. ^ a b c d Cornia PB, Hersh AL, Lipsky BA, Newman TB, Gonzales R (August 2010). "Does this coughing adolescent or adult patient accept pertussis?". JAMA. 304 (viii): 890–half dozen. doi:10.1001/jama.2010.1181. PMID 20736473. S2CID 14430946.
  19. ^ a b "Pinkish book | Pertussis | Epidemiology of Vaccine-Preventable Diseases | CDC". 2 March 2019.
  20. ^ a b c Nguyen, Van Tuong Ngoc; Simon, Lauren (1 September 2018). "Pertussis: The Whooping Cough". Primary Intendance: Clinics in Office Do. Infectious Disease. 45 (3): 423–431. doi:ten.1016/j.pop.2018.05.003. ISSN 0095-4543. PMID 30115332.
  21. ^ Heymann, David L. (ed): Pertussis; in Command of Catching Diseases Manual. p. 457. American Public Wellness Association, Washington DC, 2008, ISBN 978-0-87553-189-2
  22. ^ "Pertussis (whooping cough)". New York Country Department of Wellness. Archived from the original on 22 July 2013. Retrieved eight June 2013.
  23. ^ Inaba I (1912). "Über den Bordet-Gengouschen Keuchhustenbacillus Übertragungsversuches des Keuchenhustens auf Tiere". Z Kinderheilkd. 4: 252–264. doi:10.1007/bf02088879. S2CID 42345587.
  24. ^ Bachamn W, Burghard E (1925). "Der Nachweis der Bordet-Gengouschen Bacillen und ihre aetiologische Bedeutung für den Keuchenhusten". Z Kinderheilkd. 39: 465–483. doi:ten.1007/BF02225286. S2CID 30221200.
  25. ^ Shibley GS, Hoelscher H (September 1934). "Studies on whooping cough. I. Type-specific (Southward) and dissociation (R) forms of haemophilus pertussis". The Journal of Experimental Medicine. threescore (iv): 403–18. doi:10.1084/jem.60.4.403. PMC2132401. PMID 19870311.
  26. ^ Gustavsson OE, Röken BO, Serrander R (1990). "An epizootic of whooping coughing among chimpanzees in a zoo". Folia Primatologica; International Journal of Primatology. 55 (1): 45–50. doi:10.1159/000156498. PMID 2394416.
  27. ^ Warfel JM, Merkel TJ (Oct 2014). "The baboon model of pertussis: effective use and lessons for pertussis vaccines". Expert Review of Vaccines. 13 (10): 1241–52. doi:10.1586/14760584.2014.946016. PMID 25182980. S2CID 24133254.
  28. ^ Butynski TM et al. (eds.): Mammals of Africa vol. Ii: Primates, p. 51. Bloomsbury Publishing, London, 2013. ISBN 978-one-4081-2252-5
  29. ^ Loomis MR (1985). "Immunoprofylaxis in infant keen apes". In Graham CE, Bowen JA (eds.). Clinical Management of Babe Corking Apes. Monographs in Primatology. Vol. 5. New York: Liss. pp. 107–112.
  30. ^ Top KA, Halperin SA (2017). "Pertussis and other Bordetella infections". In Kasper DL, Fauci AS (eds.). Harrison'due south Infectious Diseases (three ed.). New York: McGraw-Hill Pedagogy. pp. 502–506. ISBN9781259835971.
  31. ^ a b c d Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ (July 2016). "Pertussis: Microbiology, Disease, Treatment, and Prevention". Clinical Microbiology Reviews. 29 (three): 449–86. doi:10.1128/CMR.00083-15. PMC4861987. PMID 27029594.
  32. ^ a b Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES (Apr 2014). "Pertussis pathogenesis—what we know and what we don't know". The Journal of Infectious Diseases. 209 (7): 982–5. doi:ten.1093/infdis/jit639. PMC3952676. PMID 24626533.
  33. ^ Melvin JA, Scheller EV, Miller JF, Cotter PA (April 2014). "Bordetella pertussis pathogenesis: electric current and future challenges". Nature Reviews. Microbiology. 12 (4): 274–88. doi:10.1038/nrmicro3235. PMC4205565. PMID 24608338.
  34. ^ Blood-red JD (2013). "Pertussis: challenges today and for the future". PLOS Pathogens. 9 (7): e1003418. doi:10.1371/journal.ppat.1003418. PMC3723573. PMID 23935481.
  35. ^ a b Ebell MH, Marchello C, Callahan M (2017). "Clinical Diagnosis of Bordetella Pertussis Infection: A Systematic Review". Journal of the American Board of Family Medicine. xxx (3): 308–319. doi:10.3122/jabfm.2017.03.160330. PMID 28484063.
  36. ^ a b c Moore A, Harnden A, Grant CC, Patel S, Irwin RS (January 2019). "Clinically Diagnosing Pertussis-associated Cough in Adults and Children: CHEST Guideline and Good Panel Study". Chest. 155 (1): 147–154. doi:10.1016/j.chest.2018.09.027. PMC6859243. PMID 30321509.
  37. ^ Pedro-Pons, Agustín (1968). Patología y Clínica Médicas (in Spanish). Vol. half-dozen (3rd ed.). Barcelona: Salvat. p. 615. ISBN84-345-1106-one.
  38. ^ "Pertussis". Euro Diagnostica. Euro Diagnostica AB. Archived from the original on 4 March 2016. Retrieved 29 February 2016.
  39. ^ Finger H, von Koenig CH (1996). "Bordetella". In Baron S, et al. (eds.). Bordetella–Clinical Manifestations. In: Barron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. ISBN0-9631172-ane-1. Archived from the original on 14 Oct 2007.
  40. ^ "Pertussis | Whooping Cough | Vaccination | CDC". world wide web.cdc.gov. Archived from the original on 26 May 2017. Retrieved 27 May 2017.
  41. ^ a b c Altunaiji S, Kukuruzovic R, Curtis N, Massie J (July 2007). "Antibiotics for whooping coughing (pertussis)". The Cochrane Database of Systematic Reviews (3): CD004404. doi:ten.1002/14651858.CD004404.pub3. PMID 17636756.
  42. ^ a b Zhang Fifty, Prietsch SO, Axelsson I, Halperin SA (September 2014). "Acellular vaccines for preventing whooping coughing in children". The Cochrane Database of Systematic Reviews. 9 (9): CD001478. doi:ten.1002/14651858.CD001478.pub6. PMID 25228233.
  43. ^ a b "Annex 6 whole cell pertussis" (PDF). World Health Organization. Archived (PDF) from the original on 24 March 2012. Retrieved 5 June 2011.
  44. ^ "Pertussis: Summary of Vaccine Recommendations". Centers for Disease Control and Prevention. Archived from the original on 29 June 2011. Retrieved v June 2011.
  45. ^ a b Mooi FR, Van Der Maas NA, De Melker HE (April 2014). "Pertussis resurgence: waning immunity and pathogen adaptation – 2 sides of the aforementioned coin". Epidemiology and Infection. Oxford University Printing. 142 (iv): 685–94. doi:10.1017/S0950268813000071. PMID 23406868. S2CID 206283573.
  46. ^ van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, van Els CA (September 2012). "Resurgence of pertussis calls for re-evaluation of pertussis animal models". Expert Review of Vaccines. 11 (ix): 1121–37. doi:ten.1586/erv.12.83. PMID 23151168. S2CID 10457474.
  47. ^ Versteegh FG, Schellekens JF, Fleer A, Roord JJ (2005). "Pertussis: a concise historical review including diagnosis, incidence, clinical manifestations and the role of handling and vaccination in management". Rev Med Microbiol. sixteen (3): 79–89. doi:ten.1097/01.revmedmi.0000175933.85861.4e. S2CID 71775827.
  48. ^ Mattoo Due south, Carmine JD (Apr 2005). "Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies". Clinical Microbiology Reviews. xviii (2): 326–82. doi:10.1128/CMR.xviii.two.326-382.2005. PMC1082800. PMID 15831828.
  49. ^ Brenzel L, Wolfson LJ, Flim-flam-Rushby J, et al. (2006). "Vaccine-Preventable Diseases". In Jamison DT, Breman JG, Measham AR, et al. (eds.). Illness Command Priorities in Developing Countries (2nd ed.). Washington DC: International Bank for Reconstruction and Evolution, World Bank. Table 20.1 Selected Vaccine-preventable Diseases and Vaccines. ISBN9780821361795. PMID 21250343.
  50. ^ Wendelboe AM, Van Rie A, Salmaso S, Englund JA (May 2005). "Duration of immunity against pertussis subsequently natural infection or vaccination". The Pediatric Infectious Disease Journal. 24 (5 Suppl): S58-61. doi:ten.1097/01.inf.0000160914.59160.41. PMID 15876927. S2CID 45434262.
  51. ^ Yang YT, Debold Five (February 2014). "A longitudinal analysis of the effect of nonmedical exemption constabulary and vaccine uptake on vaccine-targeted affliction rates". American Journal of Public Wellness. 104 (2): 371–seven. doi:10.2105/AJPH.2013.301538. PMC3935668. PMID 24328666.
  52. ^ Srugo I, Benilevi D, Madeb R, Shapiro S, Shohat T, Somekh Eastward, et al. (Oct 2000). "Pertussis infection in fully vaccinated children in day-care centers, Israel". Emerging Infectious Diseases. half dozen (five): 526–9. doi:10.3201/eid0605.000512. PMC2627963. PMID 10998384.
  53. ^ "Pertussis Vaccines:WHO Position Paper" (PDF). August 2015. Archived (PDF) from the original on 4 March 2016. It is plausible that in humans, as in nonhuman primates, asymptomatic or mildly symptomatic infections in DTaP-immunized persons may event in transmission of B. pertussis to others and may drive pertussis outbreaks.
  54. ^ "Pertussis | Whooping Cough | Causes and Transmission | CDC". www.cdc.gov. 1 February 2019. Retrieved 24 April 2020.
  55. ^ Wang K, Bettiol Due south, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, Harnden A (September 2014). "Symptomatic handling of the cough in whooping cough". The Cochrane Database of Systematic Reviews. 9 (ix): CD003257. doi:10.1002/14651858.CD003257.pub5. PMC7154224. PMID 25243777.
  56. ^ a b "Pertussis: Complications". Centers for Disease Control and Prevention. Archived from the original on 14 Baronial 2012. Retrieved 24 August 2012.
  57. ^ Carbonetti NH (March 2010). "Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biological science tools". Hereafter Microbiology. 5 (3): 455–69. doi:10.2217/fmb.09.133. PMC2851156. PMID 20210554.
  58. ^ "Pertussis | Whooping Coughing | Cases in Other Countries | CDC". www.cdc.gov. Archived from the original on ane March 2016. Retrieved 1 March 2016.
  59. ^ a b "Pertussis in Other Countries". Centers for Disease Command and Prevention (CDC). Archived from the original on 12 May 2013. Retrieved 27 May 2013.
  60. ^ "Pertussis | Whooping Coughing | Surveillance | Cases by Year | CDC". www.cdc.gov. Archived from the original on x April 2017. Retrieved 10 April 2017.
  61. ^ Gregory DS (Baronial 2006). "Pertussis: a disease affecting all ages". American Family unit Md. 74 (3): 420–6. PMID 16913160. Archived from the original on 16 May 2008.
  62. ^ Whooping Cough – Causes, Symptoms, Treatment, Diagnosis – – C-Health Archived seven July 2012 at archive.today
  63. ^ Lavelle P (xx January 2009). "A bad year for whooping cough". Australian Broadcasting Corporation. Archived from the original on 26 October 2009.
  64. ^ Kate White potato (22 February 2005). "Indelible and Painful, Pertussis Leaps Back". The New York Times. Archived from the original on 24 May 2013.
  65. ^ a b Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, et al. (3 July 2019). "Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines". Frontiers in Immunology. 10: 1344. doi:ten.3389/fimmu.2019.01344. PMC6616129. PMID 31333640.
  66. ^ Falco M (20 October 2010). "X infants expressionless in California whooping cough outbreak". CNN. Archived from the original on 21 October 2010. Retrieved 21 October 2010. Whooping cough, also known as pertussis, has claimed the 10th victim in California, in what health officials are calling the worst outbreak in 60 years.
  67. ^ "Pertussis (Whooping Cough) Outbreaks". Centers for Disease Command and Prevention. xi January 2011. Archived from the original on 19 July 2017.
  68. ^ Lin Two R (7 September 2010). "Diagnoses lagged in infant deaths". Los Angeles Times. Archived from the original on 10 September 2010. Retrieved 8 September 2010.
  69. ^ Shute N (30 September 2013). "Vaccine Refusals Fueled California'south Whooping Cough Epidemic". NPR. Archived from the original on v Oct 2013. Retrieved vi October 2013.
  70. ^ Atwell JE, Van Otterloo J, Zipprich J, Winter K, Harriman K, Salmon DA, et al. (October 2013). "Nonmedical vaccine exemptions and pertussis in California, 2010". Pediatrics. 132 (4): 624–30. doi:10.1542/peds.2013-0878. PMID 24082000.
  71. ^ Donna Gordon Blankinship (10 May 2012). "Whooping cough epidemic declared in Washington". Associated Press, Seattle Times. Archived from the original on 13 May 2012. Retrieved fourteen May 2012.
  72. ^ Washington State Department of Health (April 2012). "Whooping coughing cases reach epidemic levels in much of Washington" (PDF). Washington State Section of Health. Archived from the original (PDF) on 20 January 2015. Retrieved fourteen May 2012.
  73. ^ a b Herzog K (17 August 2012). "Wisconsin has highest rate of whooping cough". the Periodical Lookout. Archived from the original on 19 Baronial 2012. Retrieved 17 August 2012.
  74. ^ Johnson T (thirteen December 2012). "Whooping coughing epidemic alleged in Vermont". Burlington Free Press . Retrieved xiv Dec 2012.
  75. ^ Bakery JP, Katz SL (February 2004). "Childhood vaccine development: an overview". Pediatric Research. 55 (2): 347–56. doi:10.1203/01.PDR.0000106317.36875.6A. PMID 14630981.
  76. ^ "Irresolute the Face of Medicine | Dr. Leila Alice Daughtry Denmark". www.nlm.nih.gov. Archived from the original on 21 March 2015. Retrieved iii Feb 2016.
  77. ^ Bannink J. "Finding aid for the Michigan women and the whooping cough vaccine collection[s]" (PDF). Archived (PDF) from the original on 5 February 2015.
  78. ^ Sato Y, Kimura Chiliad, Fukumi H (January 1984). "Development of a pertussis component vaccine in Japan". Lancet. ane (8369): 122–6. doi:10.1016/S0140-6736(84)90061-8. PMID 6140441. S2CID 23621152.

External links [edit]

  • Pertussis at Todar's Online Textbook of Bacteriology
  • PBS NOVA – Vaccines: Calling The Shots
  • "Whooping Cough". MedlinePlus. U.Southward. National Library of Medicine.

martinezforut1955.blogspot.com

Source: https://en.wikipedia.org/wiki/Whooping_cough

0 Response to "Once You Have the Whooping Cough Vacine How Long Before You Can Be Around the Baby"

Enregistrer un commentaire

Inscription à : Publier les commentaires (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel